Drug Trial Radar · NCT04531982
Efficacy and Safety of Pimavanserin as Adjunctive Treatment for the Negative Symptoms of Schizophrenia
Last checked: Nov 20, 2026Latest source record: Aug 22, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
454
Actual
Start
Aug 5, 2020
Primary completion
Jan 25, 2024
Study completion Feb 19, 2024
Sponsor
- Lead sponsor
- ACADIA Pharmaceuticals Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 31, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the efficacy and safety of adjunctive pimavanserin compared with adjunctive placebo in the treatment of negative symptoms of schizophrenia
Conditions
- Schizophrenia
Interventions
PimavanserinDrug
Pimavanserin 34 mg, taken as two blinded 17 mg tablets once daily by mouth
PlaceboDrug
Placebo, taken as two blinded tablets once daily by mouth
Primary outcomes
What the sponsor says the trial is designed to measure.
- Negative Symptom Assessment-16 (NSA-16) Total Score - Change From Baseline to Week 26Time frame: 26 Weeks Treatment Duration
Locations
102 sites in 12 countries. Site status is shown where the registry gives one.
603-Fundación para el Estudio y Tratamiento de las Enfermedades Mentales - FETEM
Buenos Aires, Argentina
610-Clinica Privada Banfield S.A.
Buenos Aires, Argentina
625-NOVAIN Neurociencias Group
Buenos Aires, Argentina
601-CENydET- Centro Neurobiologico y de Estres Traumatico-Biopsychomedical Research Group SRL
Ciudad Autonoma Buenos Aires, Argentina
602-FunDamoS
Ciudad Autonoma Buenos Aires, Argentina
622-Instituto Medico Damic Srl
Córdoba, Argentina
624-Centro Especializado en Neurociencias CEN
Córdoba, Argentina
626-Sanatorio Prof. Leon S. Morra S.A.
Córdoba, Argentina
617-INSA Instituto de Neurociencias San Agustin S.A.
La Plata, Argentina
623-Clinica Privada de Salud Mental Santa Teresa de Avila
La Plata, Argentina
607-Resolution Psicopharmacology Research Institute
Mendoza, Argentina
454-Mental Health Center Prof. Dr. Ivan Temkov - Burgas EO Burgas; Department for Treatment of Emergency Psychiatric Conditions
Burgas, Bulgaria
533-State Psychiatric Hospital - Kardzhali, EOOD
Kardzhali, Bulgaria
569-State Psychiatric Hospital - Lovech
Lovech, Bulgaria
535-UMHAT 'Dr. Georgi Stranski', EAD
Pleven, Bulgaria
586-Medical Center Mentalcare OOD
Plovdiv, Bulgaria
563-MC-Hipokrat-N E00D
Plovdiv, Bulgaria
592-Medical center Spectar - Plovdiv EOOD
Plovdiv, Bulgaria
570-Medical Centre "Sveti Naum"
Sofia, Bulgaria
526-DCC "Sv. Vrach and Sv. Sv. Kuzma and Damyan", OOD
Sofia, Bulgaria
405-"UMHAT Alexandrovska EAD, Sofia; Clinic of Psychiatry, First Department of Psychiatry "
Sofia, Bulgaria
568-Medical Center Hera EOOD
Sofia, Bulgaria
528-Medical Center Intermedica, OOD
Sofia, Bulgaria
590-State Psychiatric Hospital - Tzarev Brod
Tsarev Brod, Bulgaria
498-DCC "Mladost M" - Varna, OOD
Varna, Bulgaria
455-Mental Health Center - Veliko Tarnovo EOOD,
Veliko Tarnovo, Bulgaria
401-Mental Health Center - Vratsa EOOD, Vratsa; Department of Psychiatry
Vratsa, Bulgaria
532-MHAT "Dr. Hristo Stambolski", EOOD
Kazanlak, Stara Zagora, Bulgaria
536-Clinic for psychiatry Vrapce
Zagreb, Croatia
537-Clinic for psychiatry Vrapce
Zagreb, Croatia
550-Clinic for psychiatry Vrapce
Zagreb, Croatia
557-Clinic for psychiatry Vrapce
Zagreb, Croatia
594-klinika za psihijatriju Sveti Ivan, n/p Igor Filipčić or Marija Zelenika
Zagreb, Croatia
512-NeuropsychiatrieHK s.r.o.
Hradec Králové, Czechia
583-Narodni ustav dusevniho zdravi
Klecany, Czechia
519-A-SHINE s.r.o.
Pilsen, Czechia
513-CLINTRIAL s.r.o.
Prague, Czechia
499-MUDr. Tibor Miklos
Prague, Czechia
456-Semmelweis University Department of Psychiatry and Psychotherapy
Budapest, Hungary
520-Nyiro Gyula Korhaz - Orszagos Pszichiatriai es Addiktologiai Intezet
Budapest, Hungary
Showing 40 of 102 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.